2023 annual financial data
Stoke Therapeutics 2023 Operating margin
Stoke Therapeutics 2023 operating margin with verified reported values.
Direct answer
Operating margin was -1,307.21%.
Operating income was -114,773,000 USD and net income was -104,699,000 USD.
Operating cash flow was -81,067,000 USD.
Get free Stoke Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 8,780,000 USD
- Operating income
- -114,773,000 USD
- Net income
- -104,699,000 USD
- Operating cash flow
- -81,067,000 USD